Moderna Reaches Analyst Target Price

In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $143.31, changing hands for $143.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuat

In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $143.31, changing hands for $143.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuat